SOX12 and cancer: Furthermore, Kaplan–Meier analysis based on TCGA datasets revealed that patients with high levels of SOX12 had shorter OS than patients with low levels of SOX12 (Fig. 1b), strongly suggesting that SOX12 contributes to the progression of these human cancers.